Biotoxtech Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2000-08-23
- Employees
- 242
- Market Cap
- -
- Website
- http://www.biotoxtech.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.
- Conditions
- Healthy
- First Posted Date
- 2013-06-28
- Last Posted Date
- 2013-06-28
- Lead Sponsor
- Biotoxtech Co., Ltd
- Registration Number
- NCT01889745
- Locations
- 🇰🇷
Asan Medical Center, Special City of Seoul, Korea, Republic of
A Phase I Clinical Study Study of the Safety, Tolerability, and Pharmacokinetics of HX-1171 in Healthy Male Subjects
- First Posted Date
- 2012-03-08
- Last Posted Date
- 2012-03-08
- Lead Sponsor
- Biotoxtech Co., Ltd
- Target Recruit Count
- 66
- Registration Number
- NCT01548391
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
News
No news found